Site Feasibility

1. Feb 28, 2025

What Does the ‘Site Feasibility’ Mean?

Site feasibility refers to the process of evaluating a potential clinical trial site’s capability and suitability to conduct a specific study. This assessment involves examining various factors such as the site’s infrastructure, staff qualifications, patient population, and regulatory compliance to determine if it can successfully carry out the trial protocol.

The site feasibility process typically includes questionnaires, interviews, and on-site visits to gather comprehensive information about the facility. By conducting thorough site feasibility assessments, sponsors and CROs can identify the most appropriate sites for their clinical trials, potentially improving study efficiency and data quality.

Why Is the ‘Site Feasibility’ Important in Clinical Research?

Site feasibility is crucial in clinical research as it directly impacts the success and efficiency of a clinical trial. By thoroughly assessing potential sites, sponsors can identify those best equipped to meet the study’s requirements, potentially reducing delays, protocol deviations, and recruitment challenges.

Furthermore, effective site feasibility contributes to data quality and patient safety. It ensures that selected sites have the necessary expertise, resources, and patient population to conduct the trial according to protocol, ultimately leading to more reliable results and smoother regulatory submissions.

Good Practices and Procedures

1. Develop a standardized site feasibility questionnaire that covers all critical aspects of the study, including patient population demographics, competing trials, and historical recruitment data.
2. Conduct virtual site tours using video conferencing tools to assess facilities and equipment when in-person visits are not feasible or cost-effective.
3. Implement a scoring system to objectively evaluate and compare potential sites based on predefined criteria aligned with the study’s specific requirements.
4. Engage with local key opinion leaders and patient advocacy groups to gain insights into the site’s reputation and access to the target patient population.
5. Establish a feedback loop with sites post-selection to continuously improve the feasibility process and refine selection criteria for future studies.

Related Terms

• Training Compliance
• Primary Endpoint
• Double-Blind Trial